Top Clinical Trials companies in the world by Price to Book Ratio (P/B)

This ranking features the top 220 Clinical Trials companies in the world ranked by Price to Book Ratio (P/B), averaging a Price to Book Ratio (P/B) of 3.63, for January 15, 2025.

Global

Clinical Trials

#	Name	Price to Book Ratio (P/B)	Reported Date	Stock Price	Change	Country
1	Ascentage Pharma Group International 1 6855.HK	191.62	Jan. 14, 2025	USD 5.19	2.25%	China
2	Guardant Health, Inc. 2 GH	112.03	Jan. 14, 2025	USD 37.46	-1.68%	United States
3	Summit Therapeutics Inc. 3 SMMT	65.06	Jan. 14, 2025	USD 16.65	-8.42%	United States
4	Telix Pharmaceuticals Limited 4 TLX.AX	51.03	Jan. 14, 2025	USD 15.47	4.25%	Australia
5	Delcath Systems, Inc. 5 DCTH	38.83	Jan. 14, 2025	USD 12.69	-0.78%	United States
6	Axsome Therapeutics, Inc. 6 AXSM	30.90	Jan. 14, 2025	USD 84.60	-5.23%	United States
7	Lumosa Therapeutics Co., Ltd. 7 6535.TWO	29.71	Jan. 14, 2025	USD 7.92	0.31%
8	TG Therapeutics, Inc. 8 TGTX	26.82	Jan. 14, 2025	USD 29.74	7.48%	United States
9	LegoChem Biosciences, Inc. 9 141080.KQ	25.34	Jan. 14, 2025	USD 80.54	1.08%
10	Blueprint Medicines Corporation 10 BPMC	24.25	Jan. 14, 2025	USD 102.56	-0.77%	United States
11	Travere Therapeutics, Inc. 11 TVTX	22.89	Jan. 14, 2025	USD 17.07	-8.18%	United States
12	Capricor Therapeutics, Inc. 12 CAPR	18.96	Jan. 14, 2025	USD 12.59	-1.02%	United States
13	OncoTherapy Science, Inc. 13 4564.T	17.65	Jan. 14, 2025	USD 0.15	4.16%	Japan
14	ABL Bio Inc. 14 298380.KQ	17.25	Jan. 14, 2025	USD 21.07	1.40%	South Korea
15	SanBio Company Limited 15 4592.T	16.37	Jan. 14, 2025	USD 4.78	-2.00%	Japan
16	Intra-Cellular Therapies, Inc. 16 ITCI	15.49	Jan. 14, 2025	USD 126.89	-0.24%	United States
17	BioArctic AB (publ) 17 BIOA-B.ST	15.29	Jan. 14, 2025	USD 17.87	3.09%	Sweden
18	Medpace Holdings, Inc. 18 MEDP	14.31	Jan. 14, 2025	USD 330.91	-5.99%	United States
19	Cambridge Cognition Holdings Plc 19 COG.L	12.52	Jan. 14, 2025	USD 0.49	0.09%	United Kingdom
20	electroCore, Inc. 20 ECOR	12.45	Jan. 14, 2025	USD 15.60	0.97%	United States
21	Clene Inc. 21 CLNN	11.76	Jan. 14, 2025	USD 4.80	-3.03%	United States
22	Hua Medicine (Shanghai) Ltd. 22 2552.HK	11.58	Jan. 14, 2025	USD 0.17	-0.02%	China
23	Rani Therapeutics Holdings, Inc. 23 RANI	11.43	Jan. 14, 2025	USD 1.28	-1.54%	United States
24	Sarepta Therapeutics, Inc. 24 SRPT	11.02	Jan. 14, 2025	USD 118.83	0.34%	United States
25	Poseida Therapeutics, Inc. 25 PSTX	11.01	Jan. 7, 2025	USD 9.50	NA	United States
26	Suven Life Sciences Limited 26 SUVEN.NS	10.62	Jan. 14, 2025	USD 1.50	-2.83%	India
27	Biodesix, Inc. 27 BDSX	10.40	Jan. 14, 2025	USD 1.15	-7.26%	United States
28	Biohaven Pharmaceutical Holding Company Ltd. 28 BHVN	10.07	Jan. 14, 2025	USD 35.57	-5.10%	United States
29	Akeso, Inc. 29 9926.HK	9.80	Jan. 14, 2025	USD 7.28	2.32%	China
30	Corcept Therapeutics Incorporated 30 CORT	9.46	Jan. 14, 2025	USD 51.66	1.18%	United States
31	Mirum Pharmaceuticals, Inc. 31 MIRM	8.81	Jan. 14, 2025	USD 43.32	-1.54%	United States
32	Oscotec Inc. 32 039200.KQ	8.81	Jan. 14, 2025	USD 17.25	0.74%	South Korea
33	Soleno Therapeutics, Inc. 33 SLNO	8.67	Jan. 14, 2025	USD 42.54	-1.21%	United States
34	TaiMed Biologics Inc. 34 4147.TWO	8.44	Jan. 14, 2025	USD 2.64	-2.78%	Taiwan
35	Avacta Group Plc 35 AVCT.L	8.14	Jan. 14, 2025	USD 0.62	-2.80%	United Kingdom
36	Vivos Therapeutics, Inc. 36 VVOS	7.94	Jan. 14, 2025	USD 5.06	4.33%	United States
37	AnaptysBio, Inc. 37 ANAB	7.89	Jan. 14, 2025	USD 14.91	1.98%	United States
38	Philogen S.p.A. 38 PHIL.MI	7.88	Jan. 14, 2025	USD 19.32	1.97%	Italy
39	Arrowhead Pharmaceuticals, Inc. 39 ARWR	7.74	Jan. 14, 2025	USD 18.05	-4.55%	United States
40	Arcellx, Inc. 40 ACLX	7.16	Jan. 14, 2025	USD 64.65	-4.02%	United States
41	Abeona Therapeutics Inc. 41 ABEO	7.10	Jan. 14, 2025	USD 5.09	-9.27%	United States
42	Oncolys BioPharma Inc. 42 4588.T	6.99	Jan. 14, 2025	USD 3.27	-0.38%	Japan
43	Vertex Pharmaceuticals Incorporated 43 VRTX	6.37	Jan. 14, 2025	USD 411.66	-0.41%	United States
44	OSE Immunotherapeutics SA 44 OSE.PA	6.04	Jan. 14, 2025	USD 6.91	0.46%	France
45	Vimta Labs Limited 45 VIMTALABS.NS	6.02	Jan. 14, 2025	USD 10.54	-1.07%	India
46	Geron Corporation 46 GERN	5.96	Jan. 14, 2025	USD 2.94	-1.34%	United States
47	Neurocrine Biosciences, Inc. 47 NBIX	5.74	Jan. 14, 2025	USD 139.51	-2.46%	United States
48	Arbutus Biopharma Corporation 48 ABUS	5.36	Jan. 14, 2025	USD 3.18	-5.08%	United States
49	AP Biosciences Inc 49 6945.TWO	5.28	Jan. 14, 2025	USD 1.60	-3.36%
50	MaaT Pharma SA 50 MAAT.PA	5.27	Jan. 14, 2025	USD 8.53	3.61%	France

1 2 3 4 5

Frequently Asked Questions

Which Clinical Trials company has the highest Price to Book Ratio (P/B) ?

The Clinical Trials company with the highest Price to Book Ratio (P/B) is Ascentage Pharma Group International (HKSE: 6855.HK) at 191.62.
Which Clinical Trials company has the lowest Price to Book Ratio (P/B) ?

The Clinical Trials company with the lowest Price to Book Ratio (P/B) is Alnylam Pharmaceuticals, Inc. (NasdaqGS: ALNY) at -302.18.

What are the top 10 Clinical Trials companies by Price to Book Ratio (P/B) ?

The top 10 Clinical Trials companies the Global by Price to Book Ratio (P/B) are Ascentage Pharma Group International, Guardant Health, Inc., Summit Therapeutics Inc., Telix Pharmaceuticals Limited, Delcath Systems, Inc., Axsome Therapeutics, Inc., Lumosa Therapeutics Co., Ltd., TG Therapeutics, Inc., LegoChem Biosciences, Inc. and Blueprint Medicines Corporation.
What are the bottom 10 Clinical Trials companies by Price to Book Ratio (P/B) ?

The bottom 10 Clinical Trials companies by Price to Book Ratio (P/B) are Alnylam Pharmaceuticals, Inc., Cytokinetics, Incorporated, Xeris Biopharma Holdings, Inc., Saniona AB (publ), Crossject Société Anonyme, Adocia SA, Hansa Biopharma AB (publ), MedinCell S.A., Rigel Pharmaceuticals, Inc. and Daré Bioscience, Inc..